Marie Robin

89PUBLICATIONS
354CO-AUTHORS
Predictive and prognostic markersTransplantation immunologyCardiovascular medicine and haematology not elsewhere classifiedHaematological tumoursEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (89)

|Oct 07, 2026
Choice of a different donor reduces relapse risk after second allogeneic SCT for MDS.

|Sep 30, 2026
Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome in young adults: A retrospective study on behalf of the EBMT Chronic Malignancies Working Party.

|Sep 12, 2026
GVHD prophylaxis with PTCy, ATG, PTCy+ATG, or no in vivo T-cell depletion in RIC matched-donor PBSC transplantation for AML and MDS.

|Apr 01, 2026
Defining remission and relapse after allogeneic hematopoietic cell transplantation in myelodysplastic/myeloproliferative neoplasms and optimization of transplantation outcomes: Recommendations from the EBMT practice harmonisation and guidelines committee.

Christopher Armstrong, Kavita Raj, Giorgia Battipaglia

|Mar 27, 2026
Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia.

Luca Lanino, Anthony M Hunter, Nico Gagelmann

|Mar 11, 2026
Deferasirox 6 months after allo-HSCT in AML/MDS: a prospective propensity-matched study.

Romain Buono, Anne Huynh, Edouard Forcade

Pageof 15

Frequent Collaborators

35 joint publications

Ibrahim Yakoug-Agha

28 joint publications

Donal P McLornan

22 joint publications

Kavita Raj

21 joint publications

Nicolaus Kröger